Guided Therapeutics (Guided Therapeutics) Forward Dividend Yield % : 0.00% (As of Jun. 07, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Guided Therapeutics Forward Dividend Yield %?

As of today (2024-06-07), the Forward Annual Dividend Yield of Guided Therapeutics is 0.00%.

As of today (2024-06-07), the Trailing Annual Dividend Yield of Guided Therapeutics is 0.00%.

GTHP's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.965
* Ranked among companies with meaningful Forward Dividend Yield % only.

Guided Therapeutics's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Guided Therapeutics's Forward Dividend Yield %

For the Medical Devices subindustry, Guided Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guided Therapeutics's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's Forward Dividend Yield % falls into.

Guided Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Guided Therapeutics (OTCPK:GTHP) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Guided Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Guided Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guided Therapeutics (Guided Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guided Therapeutics Inc (OTCPK:GTHP) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5835 Peachtree Corners East, Suite B, Norcross, GA, USA, 30092

Website

https://www.guidedinc.com

Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.

Executives

John E Imhoff	director, 10 percent owner	P.O. BOX 31083, SEA ISLAND GA 31561
Alan Grujic	director	349 FORBES AVE, SAN RAFAEL CA 94901
Michael C James	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Richard P. Blumberg	director	2357 HOBART AVENUE S.W., SEATTLE WA 98116
Lynne H Imhoff	10 percent owner	2716 SOUTH ROCKFORD ROAD, TULSA OK 74114
Gene S Cartwright	officer: Chief Executive Officer	4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Parsons & Whittemore Enterprises Corp.	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 10-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F Landegger	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK, NEW YORK NY 10573
Whittemore Collection Ltd	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 5-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Linda Rosenstock	director	5995 PLAZA DRIVE, MAIL STOP CY20-103, CYPRESS CA 90630
Jonathan M Niloff	director	C/O MATRITECH, INC., 330 NEVADA STREET, NEWTON MA 02460
Ronald W Allen	director	P O BOX 1734, ATLANTA GA 30301
Shabbir Bakir Bambot	officer: VP of R & D	4955 AVALON RIDGE PARKWAY, SUITE 300, NORCROSS GA 30071

Guided Therapeutics (Guided Therapeutics) Headlines

From GuruFocus

Dr. Gene Cartwright, CEO of Guided Therapeutics Joins Everett Jolly on Uptick Newswire's “Stock Day” Podcast to Discuss LuViva® Advanced Cervical Scan

By Marketwired Marketwired • 05-16-2018